Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice

Antioxidants and Redox Signaling

Volumn 14, Issue 11, 2011, Pages 2121-2135

  Spruss, Astrid ^a   Kanuri, Giridhar ^a   Uebel, Kirsten ^a   Bischoff, Stephan C ^a   Bergheim, Ina ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DRINKING WATER; ENDOTOXIN; FRUCTOKINASE; FRUCTOSE; GLUTATHIONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; NITRITE; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; RETINOL BINDING PROTEIN 4; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARBOHYDRATE INTAKE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY LIVER; INFLAMMATION; INSULIN RESISTANCE; LIPID PEROXIDATION; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ALDEHYDES; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTOXINS; FATTY LIVER; FRUCTOKINASES; FRUCTOSE; GLUTATHIONE; I-KAPPA B PROTEINS; INSULIN RESISTANCE; KUPFFER CELLS; LIPID PEROXIDATION; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; WEIGHT GAIN;

MUS;

EID: 79956085062     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3263     Document Type: Article

References (44)

1. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, and Diehl AM. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51: 1961-1971, 2010.
2. Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, and Sela BA. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma tri-glyceride reduction. Hypertension 45: 1012-1018, 2005. (Pubitemid 40628952)
3. Ackerman Z, Oron-Herman M, Rosenthal T, Pappo O, Link G, Sela BA, and Grozovski M. Effects of amlodipine, cap-topril, and bezafibrate on oxidative milieu in rats with fatty liver. Dig Dis Sci 53: 777-784, 2008. (Pubitemid 351317066)
4. Adams LA, Lymp JF, St SJ, Sanderson SO, Lindor KD, Feldstein A, and Angulo P. The natural history of nonalco-holic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121, 2005. (Pubitemid 41002048)
5. Armutcu F, Coskun O, Gurel A, Kanter M, Can M, Ucar F, and Unalacak M. Thymosin alpha 1 attenuates lipid perox-idation and improves fructose-induced steatohepatitis in rats. Clin Biochem 38: 540-547, 2005. (Pubitemid 40693468)
6. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124: 778-790, 2003. (Pubitemid 36268494)
7. Arteel GE. Alcohol-induced oxidative stress in the liver: in vivo measurements. Methods Mol Biol 447: 185-197, 2008.
8. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, and Bellentani S. Prevalence of and risk factors for nonal-coholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42: 44-52, 2005. (Pubitemid 40911310)
9. Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaser-ouni S, McClain CJ, and Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48: 983-992, 2008.
10. Brun P, Castagliuolo I, Di L, V, Buda A, Pinzani M, Palu G, and Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-G525, 2007.
11. Charbonneau A and Marette A. Inducible nitric oxide syn-thase induction underlies lipid-induced hepatic insulin re-sistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes 59: 861-871, 2010.
12. Chen Y, Hozawa S, Sawamura S, Sato S, Fukuyama N, Tsuji C, Mine T, Okada Y, Tanino R, Ogushi Y, and Nakazawa H. Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet. Biochem Biophys Res Commun 326: 45-51, 2005. (Pubitemid 39573198)
13. Chen Y, Hozawa S, Sawamura S, Sato S, Fukuyama N, Tsuji C, Mine T, Okada Y, Tanino R, Ogushi Y, and Nakazawa H. Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet. Biochem Biophys Res Commun 326: 45-51, 2005. (Pubitemid 39573198)
14. Garcia-Monzon C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A, Larranaga E, and Moreno-Otero R Characterization of pathogenic and prog-nostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33: 716-724, 2000.
15. Garcia-Ruiz C and Fernandez-Checa JC. Mitochondrial glutathione: hepatocellular survival-death switch. J Gastro-enterol Hepatol 21 Suppl 3: S3-S6, 2006. (Pubitemid 44266539)
16. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, and Kahn BB. Retinol-binding protein 4 and insulin resis-tance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563, 2006. (Pubitemid 43882351)
17. Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, and Bergheim I. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298: G335-G344, 2010.
18. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, and Grisham MB. Enhanced post-ischemic liver injury in iNOS-deficient mice: a cautionary note. Biochem Biophys Res Commun 284: 972-976, 2001. (Pubitemid 32924743)
19. Jurgens H, Haass W, Castaneda TR, Schurmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, and Tschop MH. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 13: 1146-1156, 2005.
20. Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, and Bergheim I. Role of tumor necrosis factor alpha (TNFalpha) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 2010 [Epub ahead of print]; DOI: 10.1016/j.jnutbio.2010.04.007.
21. Kanuri G, Weber S, Volynets V, Spruss A, Bischoff SC, and Bergheim I. Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J Nutr 139: 482-487, 2009.
22. Levi B and Werman MJ. Long-term fructose consumption accelerates glycation and several age-related variables in male rats. J Nutr 128: 1442-1449, 1998. (Pubitemid 28399940)
23. Lin MC, Kao SH, Chung PJ, Chan KC, Yang MY, and Wang CJ. Improvement for high fat diet-induced hepatic injuries and oxidative stress by flavonoid-enriched extract from Nelumbo nucifera leaf. JAgric Food Chem 57:5925-5932, 2009.
24. Malaguarnera M, Di RM, Nicoletti F, and Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med 87: 679-695, 2009.
25. Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE, Kraus DW, rley-Usmar VM, and Bailey SM. High fat diet induces dysregulation of he-patic oxygen gradients and mitochondrial function in vivo. Biochem J 417: 183-193, 2009.
26. McKim SE, Gabele E, Isayama F, Lambert JC, Tucker LM, Wheeler MD, Connor HD, Mason RP, Doll MA, Hein DW, and Arteel GE. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125: 1834-1844, 2003. (Pubitemid 37500447)
27. Miele L, Valenza V, La TG, Montalto M, Cammarota G, Ricci R, Masciana R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, and Grieco A. Increased intestinal permeability and tight junction alterations in non-alcoholic fatty liver disease. Hepatology 49: 1877-1887, 2009.
28. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, and Abdelmalek MF. Fructose consump-tion as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48: 993-999, 2008.
29. Park SY, Baik YH, Cho JH, Kim S, Lee KS, and Han JS. Inhibition of lipopolysaccharide-induced nitric oxide syn-thesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in raw 264.7 cells. Cytokine 44: 126-134, 2008.
30. Ragheb R, Medhat AM, Shanab GM, Seoudi DM, and Fantus IG. Links between enhanced fatty acid flux, protein kinase C and NFkappaB activation, and apoB-lipoprotein production in the fructose-fed hamster model of insulin resistance. Bio-chem Biophys Res Commun 370: 134-139, 2008.
31. Rai RM, Lee FY, Rosen A, Yang SQ, Lin HZ, Koteish A, Liew FY, Zaragoza C, Lowenstein C, and Diehl AM. Impaired liver regeneration in inducible nitric oxide syn-thasedeficient mice. Proc Natl Acad Sci USA 95: 13829-13834, 1998. (Pubitemid 28523058)
32. Ramirez-Tortosa MC, Ramirez-Tortosa CL, Mesa MD, Granados S, Gil A, and Quiles JL. Curcumin amelio-rates rabbits's steatohepatitis via respiratory chain, oxida-tive stress, and TNF-alpha. Free Radic Biol Med 47: 924-931, 2009.
33. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, and Davis RJ. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539-1543, 2008.
34. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, and Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192, 2001. (Pubitemid 32246672)
35. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Green-wald A, Diehl AM, and Magnuson T. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 49: 1578-1583, 2004. (Pubitemid 39335538)
36. Spruss A and Bergheim I. Dietary fructose and intesti-nal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem 20: 657-662, 2009.
37. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, and Bergheim I. Toll-like receptor 4 is involved in the de-velopment of fructose-induced hepatic steatosis in mice. Hepatology 50: 1094-1104, 2009.
38. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Ko-nigsrainer A, Maier KP, Bischoff SC, and Bergheim I. Non-alcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator in-hibitor 1 concentrations and with fructose intake. J Nutr 138: 1452-1455, 2008.
39. Tiegs G, Kusters S, Kunstle G, Hentze H, Kiemer AK, and Wendel A. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury. J Pharmacol Exp Ther 287: 1098-1104, 1998. (Pubitemid 29131626)
40. Tipoe GL, Liong EC, Leung TM, and Nanji AA. A voluntary oral-feeding rat model for pathological alcoholic liver injury. Methods Mol Biol 447: 11-31, 2008.
41. Venkatraman A, Shiva S, Wigley A, Ulasova E, Chhieng D, Bailey SM, and rley-Usmar VM. The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 40: 565-573, 2004. (Pubitemid 39265577)
42. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, and Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206-211, 2001. (Pubitemid 32141844)
43. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, and Kahn BB. Serum retinol binding protein 4 contributes to insulin re-sistance in obesity and type 2 diabetes. Nature 436: 356-362, 2005. (Pubitemid 41065039)
44. Yang SQ, Lin HZ, Mandal AK, Huang J, and Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34: 694-706, 2001. (Pubitemid 32927993)